RDPAC Member Firms Invest Over RMB 20 Billion In China In 2006-10
This article was originally published in PharmAsia News
Executive Summary
The R&D-based Pharmaceutical Association Committee (RDPAC)'s 37 multinational biopharmaceutical member firms invested over RMB 20 billion ($3.03 billion) in China's drug market during the 11th Five-Year Plan period, according to the committee